ArticleFrontiers in immunology2025

Single-cell ligand-receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer.

Chuanzhi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.